Clinical Trial Update: Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether cefoxitin or piperacillin-tazobactam prophylaxis prevents postoperative surgical site infections after pancreatoduodenectomy; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Cefoxitin (Cefoxitin)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer, Pancreas Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-10-21